GeneTherapy.ISTH.org: Recent Episodes

ISTH

Podcast by ISTH

Importance of Monitoring Individuals With Hemophilia for Safety and Efficacy - Short Term/Long Term by ISTH

Gene Therapy in Hemophilia Ongoing and Future Research and What to Expect by ISTH

Patient Perspectives for Hemophilia in Gene Therapy by ISTH

Gene Therapy as a Global Solution by ISTH

Preparing Treatment Centers for Administration by ISTH

Gene Therapy for Hemophilia A and B Compared to Available Treatments by ISTH

Listen as Dr. Margareth Ozelo from the University of Campinas in Brazil discusses the latest clinical trial updates in Gene Therapy for Hemophilia B.

This podcast is part of a comprehensive educational resource designed by leading experts for the global hemophilia community to help you stay abreast of the evolving science and latest clinical advancements in gene therapy in hemophilia. Visit www.genetherapy.isth.org for more information.

Listen as Dr. Margareth Ozelo from the University of Campinas in Brazil discusses the latest clinical trial updates in Gene Therapy for Hemophilia A.

This podcast is part of a comprehensive educational resource designed by leading experts for the global hemophilia community to help you stay abreast of the evolving science and latest clinical advancements in gene therapy in hemophilia. Visit www.genetherapy.isth.org for more information.

History of EAHAD and the Upcoming Congress by ISTH

ISTH Gene Therapy for Hemophilia Initiative and EAHAD’s Role by ISTH

EAHAD Gene Therapy Work Group by ISTH

Andrew D. Leavitt, MD discusses the reliability and accessibility of gene therapy for hemophilia.

Latest Advances in Gene Therapy for Hemophilia by ISTH

This activity is intended for physicians (hematologists), nurse practitioners, physician assistants, and nurses managing patients with hemophilia. The activity is also intended for scientists with an interest in basic, translational, and clinical research in hemophilia around the world.

This activity is intended for physicians (hematologists), nurse practitioners, physician assistants, and nurses managing patients with hemophilia. The activity is also intended for scientists with an interest in basic, translational, and clinical research in hemophilia around the world.

This activity is intended for physicians (hematologists), nurse practitioners, physician assistants, and nurses managing patients with hemophilia. The activity is also intended for scientists with an interest in basic, translational, and clinical research in hemophilia around the world.

This activity is intended for physicians (hematologists), nurse practitioners, physician assistants, and nurses managing patients with hemophilia. The activity is also intended for scientists with an interest in basic, translational, and clinical research in hemophilia around the world.

This activity is intended for physicians (hematologists), nurse practitioners, physician assistants, and nurses managing patients with hemophilia. The activity is also intended for scientists with an interest in basic, translational, and clinical research in hemophilia around the world.

What Do Hemophilia Treatment Centers Need to Consider for the Availability of Gene Therapy? by ISTH

Laboratory Measurement of Hemophilia Gene Therapy Products/Factor Activity by ISTH

Hemophilia Gene Therapy and Patients with History of Inhibitors by ISTH

Interpreting Vector Doses in Hemophilia Gene Therapy Clinical Trials by ISTH

Long-Term Monitoring Following Hemophilia Gene Therapy by ISTH

Response to AAV Vector Delivery by ISTH

Gene Editing and Cell-Based Therapy for Hemophilia by ISTH

Factor IX Gene Therapy Clinical Trials Update by ISTH

Next Generation Gene Therapies for Hemophilia by ISTH

Factor VIII Gene Therapy Clinical Trials Update by ISTH

Challenges Associated with AAV as a Tool for Delivering Therapeutic Transgenes by ISTH